Researchers are working to make blood testing for early-stage type 1 diabetes more accessible, helping families prepare sooner and reduce the risk of diagnosis in diabetic ketoacidosis. Type 1 diabetes does not always announce itself with a crisis. In many…
New research highlighted by Breakthrough T1D points to finerenone, experimental eye drops and more flexible care as scientists seek to reduce complications and the daily mental burden of type 1 diabetes. For people living with type 1 diabetes, the daily…
Researchers are exploring smarter insulin systems, ketone monitoring and digital twins to reduce the mental burden of type 1 diabetes, but uneven access could limit their impact. Breakthrough T1D says new diabetes technologies and artificial intelligence could ease the daily…
Building muscle can improve insulin sensitivity, cardiovascular health and healthy ageing, while simple body-weight exercises may deliver benefits without a gym membership. Strength training is often sold as a route to bigger muscles, but its value extends well beyond appearance.…
Income, education, gender and geography continue to influence exposure to risk factors and access to screening, diagnosis and treatment, according to a new WHO report. The World Health Organization has warned that inequality continues to shape who develops non-communicable diseases…
Diabetes Canada chief executive Laura Syron’s experience highlights the difficult balance between visibility, privacy and fears of being judged less capable at work. Laura Syron says leading a national diabetes charity while living with type 2 diabetes has meant learning…
An exploratory trial suggests ultrasound-based stiffness measurements could reveal exercise-related muscle changes in type 2 diabetes before HbA1c or muscle thickness, although clinical validation is still needed. A small exploratory study published in BMC Endocrine Disorders suggests that shear wave…
A study of more than 70,000 US adults found lower rates of psychiatric hospitalisation and emergency care among people with schizophrenia and type 2 diabetes who started GLP-1 medicines, although researchers caution that the findings do not prove a direct…
Viking Therapeutics is testing whether a redesigned dosing plan can overcome earlier side effects as it advances tablet and injectable versions of its obesity drug VK2735. Viking Therapeutics has given investors another reason to focus on its obesity pipeline after…
Clinicians are being urged to screen relatives and reconsider autoimmune diabetes in atypical adult and pregnancy cases as earlier diagnosis opens the door to treatment before symptoms develop. Early-stage type 1 diabetes moved into the spotlight at CVRM Professional Care…
